NPC
IRD

National Planning Corporation’s Opus Genetics IRD Stock Holding History

National Planning Corporation’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4
Closed -$1.6K – 2102
2014
Q4 		$1.6K Buy
+4
New +$1.38K ﹤0.01% 2617

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

National Planning Corporation's IRD Position: Q1 2015 in Review

National Planning Corporation sold out of Opus Genetics (IRD) in Q1 2015, closing a stake of 4 shares — an estimated $1.6K sold.

National Planning Corporation first reported a position in IRD in Q4 2014 and held it in 1 quarter. The position peaked at $1.6K in Q4 2014. 35 funds tracked by Wall St. Rank hold IRD as of Q1 2015.

  • National Planning Corporation reported no remaining Opus Genetics position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 4 Opus Genetics shares in Q1 2015, an estimated $1.6K.
  • National Planning Corporation first reported a position in Opus Genetics in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's Opus Genetics position peaked at $1.6K in Q4 2014.
  • 35 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.